Patent · US Expired

2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient

US7189711B2 · kind B2 · utility

1Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 19, 2001
Grant dateMar 13, 2007
Priority date
Expiry dateNov 10, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention refers to novel 2,3-benzodiazepine derivatives of formula (I) and pharmaceutical compositions containing the same as the active ingredient. The novel compounds antipasmodic, muscle relaxant and neuroprotective activities. In formula I; X represents a hydrogen atom, a chloro atom or a methoxy group; Y stands for a hydrogen atom or a halo atom; Z means a methyl group or a chloro atom; R is a C1-4 alkyl group or a group of the formula —NR1R2, wherein R1 and R2 represent, independently, a hydrogen atom, a C1-4 alkyl group, a C1-4 alkoxy group or a C3-6 cycloalkyl group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.